Biometric CRO Quanticate will work with PhaseV, a machine learning company developing software for clinical trials, to launch a new service that aims to help sponsors design and optimize adaptive ...

The idea of utilizing “big data” in the context of clinical trials has been a topic of conversation for more than a decade. Trial sponsors are faced with vast amounts of diverse data and corresponding ...

As clinical trials race against time, especially during global health emergencies, data-driven patient enrollment has become ...

Chapel Hill-based University of North Carolina Lineberger Comprehensive Cancer Center has been awarded up to $28 million to develop an adaptive clinical trial targeting metastatic breast cancer. The ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology. In a new collaboration, Alimentiv will combine PhaseV's machine learning ...

The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis. With an initial $4 million in funding, the ...

Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials. Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate ...

The press release below was prepared by the Pancreatic Cancer Action Network. View the original here. The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic ...

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for ...

Post hoc analysis of the AdaptResponse global randomized trial suggests the value of adaptive vs conventional cardiac resynchronization therapy (CRT) in patients with symptomatic heart failure (HF), ...